← All Protalix Biotherapeutics, INC filings

Protalix Biotherapeutics, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

AMEX
PLX
Protalix Biotherapeutics, INC
DEF: Protalix BioTherapeutics Seeks Stockholder Approval for Director Elections, Executive Pay, and Auditor Ratification at 2025 Annual Meeting
Protalix BioTherapeutics is holding its 2025 Annual Meeting of Stockholders on June 26, 2025, to vote on director elections, executive compensation, and the ratification of its independent auditor.
AMEX
PLX
Protalix Biotherapeutics, INC
DEFA14A: Protalix BioTherapeutics Announces Change of Location for 2024 Annual Meeting
Protalix BioTherapeutics has changed the location of its 2024 Annual Meeting of Stockholders, while the date and time remain the same.
AMEX
PLX
Protalix Biotherapeutics, INC
DEF 14A: Protalix BioTherapeutics Seeks Stockholder Approval for Director Elections, Executive Pay, and Stock Incentive Plan Amendments
Protalix BioTherapeutics is holding its 2024 Annual Meeting of Stockholders to vote on the election of directors, executive compensation, amendments to the stock incentive plan, and the ratification of its independent accounting firm.